Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for hospitalized COVID-19 patients with ARDS
IRCT20081027001411N3Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of prednisolone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Radiographic features findings, Mortality rate and 3 more. Started Mar 2020; status: completed.
02
Drugs
prednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20081027001411N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20081027001411N3.